InvestorsObserver
×
News Home

Should Biotechnology Stock Rocket Pharmaceuticals Inc (RCKT) Be in Your Portfolio Wednesday?

Wednesday, March 13, 2024 12:14 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Rocket Pharmaceuticals Inc (RCKT) Be in Your Portfolio Wednesday?

The 73 rating InvestorsObserver gives to Rocket Pharmaceuticals Inc (RCKT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 88 percent of stocks in the Biotechnology industry, RCKT’s 73 overall rating means the stock scores better than 73 percent of all stocks.

Overall Score - 73
RCKT has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on RCKT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Rocket Pharmaceuticals Inc Stock Today?

Rocket Pharmaceuticals Inc (RCKT) stock has gained 2.92% while the S&P 500 is down -0.1% as of 12:13 PM on Wednesday, Mar 13. RCKT is higher by $0.79 from the previous closing price of $27.06 on volume of 145,059 shares. Over the past year the S&P 500 is higher by 31.92% while RCKT is higher by 48.69%. RCKT lost -$2.92 per share the over the last 12 months. Click Here to get the full Stock Report for Rocket Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App